MTOR and diabetes mellitus: Urolithin A alleviates diabetes and pancreatic damage by activating the AKT/mTOR pathway to regulate insulin signaling and autophagy to reduce oxidation, inflammation and apoptosis in the pancreas of type 2 diabetic mice [27].